Page 27 - Sofinnova Partners News Today

/PRNewswire/ -- EnginZyme, a leading developer of cell-free biomanufacturing processes, today announced that the company has signed a joint development...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

/PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of first-in-class allosteric therapies targeting...

/PRNewswire/ -- EnginZyme, a leading developer of cell-free biomanufacturing processes, today announced that the company has signed a joint development...

/PRNewswire/ -- The "Alzheimers Disease Market (2nd edition) by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia,...

/PRNewswire/ -- The "Alzheimers Disease Market (2nd edition) by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia,...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Atomico, the VC firm set up by Skype co-founder Niklas Zennstrom, is close to announcing a new start-up fund worth around $1.2 billion, according to sources.

Financing round co-led by 5AM Ventures, Roche Venture Fund and Sofinnova Partners with participation from LimmaTech Biologics AG GlycoEra AG announced today the close of a CHF 45 million ($49 million)

Sphere Fluidics, a UK company that has developed and is commercializing single cell analysis systems underpinned by its picodroplet technology, has just closed a US$40m investment round.